MAD2L1 and hepatocellular carcinoma: To explore prognostic biomarkers for HCC, we utilized UALCAN to analyze the effect of the expression level of the crucial genes on HCC patient survival, and found that the high expressions of CDK1, CCNB1, CCNB2, MAD2L1, and TOP2A were associated with poor survival of HCC patients.